Detalhe da pesquisa
1.
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor.
Eur J Nucl Med Mol Imaging
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771516